DR.WU Skincare Co., Ltd. · TPEX:6523

DR.WU Skincare — Investor Conference hosted by SinoPac Securities (September 2022)

14 slides from DR.WU Skincare's conference presentation, Sep 21, 2022

  1. Slide 1: DR. WU Skincare Co., Ltd Investor Meeting

    DR. WU Skincare Co., Ltd Investor Meeting 2022.09.21

  2. Slide 2: Disclaimer

    Disclaimer • The information and forecast contained in this presentation and released at the same time, including the information regarding business outlook, financial status, and business forecast, is produced according to the internal data of this Company and the status of overall macroeconomic de

  3. Slide 3: Agenda

    01 Introduction to DR.WU Skincare Agenda 02 2022 1H Financial Performance

  4. Slide 4: Introduction to DR.WU Skincare

    01 Introduction to DR.WU Skincare

  5. Slide 5: Company Introduction: Quick Facts about Us

    Company Introduction Quick Facts about Us • Founded:2003 • Co-Founders: Dr. Wu & Eric Wu • Listing on TPEX:2016 • Market Capital:TWD 4.5 billion (Sep.2022) • Revenue: TWD 1.1 billion (FY21) • Product: 10 Skin Care Lines • Sales Channel:8 Countries • Employee:110 staffs

  6. Slide 6: Asia's Leading Derma Skincare: Our Milestones

    Asia’s Leading Derma Skincare Our Milestones Product Expansion to DR.WU Officially Beauty Supplements Incepted No 2. Hero Product New Premium Brand Intensive Renewal Serum No 4. Hero Product Launched - Redermx with Mandelic Acid Glutalight Intensive No1. Hero Product Whitening Serum Intensive Hydrat

  7. Slide 7: Our Philosophy & Mission

    Company Introduction Our Philosophy & Mission Asia’s Leading Derma Skincare ✓ DR.WU is a line of highly effective skincare products developed with advanced patented technologies to target various problems in Asian skins. ✓ Our philosophy behind our pursuit for enhancing beauty and wellness is throug

  8. Slide 8: Continue To Enhance ESG and Sustainability

    Continue To Enhance ESG and Sustainability Environmental Support Advocate Diversity Friendly Communities & Well-being • Almost 90% Already Recyclable • Supported Burn Survivors • More Than 90% of Employees Packaging • Advocated Anti-violence Campaign Identify as Female • Replaced 500K plastic-made t

  9. Slide 9: 2022 1H Financial Results

    DR.WU 2022 1H Financial Results

  10. Slide 10: DR.WU Financial Performance

    DR.WU Financial Performance Maintained Momentum with Improved Profitability Revenue Breakdown by Channels Margins 1H22 Channel 1H21 1H22 YoY Contribution 69% 70% 69% Physical Taiwan 215,873 234,380 9% 55% 61% 63% 58% Online Taiwan 122,948 134,969 10% 32% 44% 38% 37% Taiwan subtotal 338,821 369,349 9

  11. Slide 11: Historical Dividend Payout

    Historical Dividend Payout - Average Cash Dividend Payout Ratio > 90% NTD - Issued by quarterly basis since 2021 2016-2Q22 EPS & Cash Dividends 14.68 15.22** 14.0 * EPS Cash dividend 7.06 6.60 6.58 4.26 3.86 2.78 2.50 2.46 2.0 2.0 0.55 0.5 1.17 2016 2017 2018 2019 2020 2021 1Q22 2Q22 * NT$10 cash di

  12. Slide 12: Consolidate Income Statement

    Consolidate Income Statement NT$ ‘000 2Q21 2Q22 1H21 1H22 Consolidate YoY% YoY% Amount % Amount % Amount % Amount % Net Revenue 235,260 100.0% 165,799 100.0% -29.5% 472,820 100.0% 423,224 100.0% -10.5% Operating Costs 98,421 41.8% 52,558 31.7% 172,030 36.4% 129,967 30.7% Gross Profit 136,839 58.2% 1

  13. Slide 13: Balance Sheet & Key Indices

    Balance Sheet & Key Indices NT$ ‘000 Selected Items 2021.06.30 % 2022.03.31 % 2022.06.30 % Cash and Cash Equivalents 628,986 29% 851,673 46% 638,548 35% Financial Assets at Amortized Cost 772,200 35% 567,300 30% 822,900 45% Accounts Receivable 171,156 8% 186,267 10% 83,546 5% Inventories 131,429 6%

  14. Slide 14: Thank you

    Thank you Contact Information Cheryl Lin, Investor Relations TEL:+886-2-2517-9888 E-mail:[email protected]

DR. WU Skincare — Investor Conference hosted by SinoPac Securities (September 2022) on 6ix